First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers.

David S HongAparna ParikhGeoffrey I ShapiroAndrea VargaAung NaingFunda Meric-BernstamÖzlem AtamanLarisa ReydermanTerri A BinderMin RenMingjie LiuSatish DayalAmy Y SiuPallavi SachdevLucy XuVijay Bhagawati-PrasadIlian TchakovChean Eng OoiXingfeng BaoAurélien Marabelle

Published in: Journal for immunotherapy of cancer (2021)

NCT02540291.

Keyphrases

endothelial cells
pluripotent stem cells
young adults